Clinical Trial

UNTOLD Ovarian Cancer Unmet Needs Survey

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to comprehensively measure ongoing concerns and unmet needs of individuals living with ovarian cancer. To accomplish this, the UNderstanding The experience of Ovarian cancer - Life after Diagnosis (UNTOLD) study will be conducted using a mixed-methods approach. Ovarian cancer survivors will be enrolled to participate in UNTOLD to complete a one-time survey regarding their experiences. Up to 40 survivors will be subsequently identified to complete a follow-up interview. To ensure these sample sizes, along with a representative sample, a combined recruitment strategy will be employed using the California Cancer Registry (population-based) and recruitment through ovarian cancer advocacy groups.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-08; most recent amendment 2026-07-06.
Status change: Not Yet Recruiting → Recruiting 2025-07-16
Trial Details
NCT Number NCT07070726
Lead Sponsor Masonic Cancer Center, University of Minnesota
Collaborators: Centers for Disease Control and Prevention
Conditions Ovarian Cancer
Enrollment 2,000 participants
Start Date 2025-07-10
Primary Completion 2027-06-30 (estimated)
Study Completion 2029-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-08